Login
Walgreens Boots Alliance NASDAQ: WBA
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company
| Name | Walgreens Boots Alliance |
| Ticker | WBA |
| Exchange | NASDAQ |
| Sector | Health Care |
| Industry | Healthcare Supply Chain & InfoTech |
| Price | 48.92 |
| 52W Low/High | 33.52 / 54.47 |
| Market cap | 42 B |
| 1Y Total Return |
-6.69%
Below Average |
| 1Y Volatility |
49.28%
Less Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company
Details
| Ticker | WBA |
| Name | Walgreens Boots Alliance |
| ISIN | US9314271084 |
| CUSIP | 931427108 |
| Exchange | NASDAQ |
| Sector | Health Care |
| Industry | Healthcare Supply Chain & InfoTech |
| Country | USA |
| Currency | U.S. Dollar |
| In Index(ices) |
|
Share as of 1/15/21
| Close Price | 48.92 |
| 52W Low/High | 33.52 / 54.47 |
| Market cap | 42 B |
| 1Y Total Return |
-6.69%
Below Average |
| 1Y Volatility |
49.28%
Less Risk |
| Beta | 0.95 |
| PE (trailing) |
94.08
High |
| 12M Dividends | 1.84 |
| Last Dividend Date | 11/18/20 |
| Dividend Yield | 3.76% |
Fin. Strength
| Net Profit Margin | 0.3% |
| Cash from Op. / Cur. Liabilities | 0.20 |
| Diluted Earnings / Share | 0.52 |
| ROE | 2.1% |
| ROIC | 2.7% |
| Price / Revenue | 0.3 |
| Price / Book | 2.1 |
| Price / CF | 7.9 |
| Current Ratio | 0.7 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 1.95 |
| in Mils USD |
rolling-year up to September
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
139,537
|
136,866
|
131,537
|
118,214
|
117,351
|
103,444
|
|
| Gross Profit |
28,017
|
30,076
|
30,792
|
29,162
|
29,874
|
26,924
|
|
| R&D |
0
|
0
|
0
|
0
|
0
|
0
|
|
| EBITDA |
3,382
|
7,312
|
8,408
|
7,185
|
7,484
|
7,623
|
|
| Operating Income |
1,313
|
4,998
|
6,289
|
5,484
|
6,001
|
4,668
|
|
| Net Income exc. Extra |
456
|
3,982
|
5,024
|
4,078
|
4,173
|
4,220
|
|
| per Share | |||||||
| Diluted avg Shares |
880
|
924
|
995
|
1,079
|
1,091
|
1,054
|
|
| EPS exc. Extra |
0.52
|
4.31
|
5.05
|
3.78
|
3.82
|
4.00
|
|
| Dividend |
1.84
|
1.78
|
1.64
|
1.53
|
1.46
|
1.37
|
|
| Div. Yield (an.) |
4.84%
|
3.47%
|
2.39%
|
1.87%
|
1.80%
|
1.62%
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
87,174
|
67,598
|
68,124
|
66,009
|
72,688
|
68,782
|
|
| Cash, Eq & Invt ShortTerm |
516
|
1,023
|
785
|
3,301
|
9,807
|
3,000
|
|
| Total Current Assets |
18,073
|
18,700
|
17,846
|
19,753
|
25,883
|
19,657
|
|
| Total Non-Current Assets |
69,101
|
48,898
|
50,278
|
46,256
|
46,805
|
49,125
|
|
| Intangibles |
26,021
|
27,436
|
28,697
|
25,788
|
25,829
|
28,723
|
|
| Total Liabilities |
66,038
|
43,446
|
41,435
|
37,735
|
42,407
|
37,482
|
|
| Total Current Liabilities |
27,070
|
25,769
|
21,667
|
18,547
|
17,013
|
16,557
|
|
| Long Term Debt |
38,968
|
17,677
|
19,768
|
19,188
|
25,394
|
20,925
|
|
| Shareholder equity |
20,637
|
23,512
|
26,007
|
27,466
|
29,880
|
30,861
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
5,484
|
5,594
|
8,263
|
7,255
|
7,847
|
5,664
|
|
| Depreciation |
1,927
|
2,038
|
1,770
|
1,654
|
1,718
|
1,742
|
|
| Cash from Investing |
-1,297
|
-2,307
|
-5,501
|
-843
|
-3,517
|
-4,276
|
|
| Capex |
1,374
|
1,702
|
1,367
|
1,351
|
1,325
|
1,251
|
|
| Cash from Financing |
-4,647
|
-3,047
|
-5,295
|
-12,934
|
2,606
|
-915
|
|
| Stock Issued |
-1,534
|
-3,986
|
-5,054
|
-5,003
|
-917
|
-723
|
|
| Debt (LT) Issued |
-1,208
|
2,508
|
1,596
|
-6,163
|
5,229
|
1,587
|
|
| Free Cash Flow |
3,677
|
8,538
|
10,597
|
12,850
|
-971
|
5,651
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
0.3%
|
2.9%
|
3.8%
|
3.4%
|
3.6%
|
4.1%
|
|
| NCFO / Op.Income |
417.7%
|
111.9%
|
131.4%
|
132.3%
|
130.8%
|
121.3%
|
|
| Current Ratio |
0.7
|
0.7
|
0.8
|
1.1
|
1.5
|
1.2
|
|
| Financial Leverage D/E |
1.95
|
0.72
|
0.55
|
0.47
|
0.64
|
0.47
|
|
| Return on Capital Avg |
2.7%
|
11.0%
|
11.7%
|
10.5%
|
9.8%
|
10.9%
|
|
| Return on Shareholder Equity |
2.1%
|
16.1%
|
18.8%
|
14.2%
|
13.7%
|
16.4%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available